[Reduced excretion of total gonadotropins during use of Elipten in breast neoplasms].
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000616:Aminoglutethimide / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006062:Gonadotropins / Q000652:urine*; D006801:Humans; D008875:Middle Aged; D011728:Pyridones / Q000627:therapeutic use*
D015068:17-Ketosteroids; D000814:Aniline Compounds; D000927:Anticonvulsants; D006062:Gonadotropins; D011728:Pyridones; D000616:Aminoglutethimide
Snizhenie ékskretsii total'nykh gonadotropinov éliptenom pri rake molochnoĭ zhelezy.